Chemkart India IPO Highlights Investors Should Know
The global nutraceutical market is valued at nearly USD 400 billion, bringing together the worlds of food, medicine, and science. It’s one of the fastest-growing industries today. Chemkart India, with its presence in the nutraceutical space, has been part of this journey. The company is taking a big step forward and going public. This move marks an exciting new chapter for Chemkart as it aims to grow.
The Chemkart India IPO lead manager is Smart Horizon Capital Advisors, while the registrar of this IPO is Bigshare Services Limited.
Check the RHP for more Chemkart India IPO Details.
Note: For 50% of the shares, the anchor lock-in period expires 30 days following the actual allocation, and for the remaining part, it ends 90 days later.
Chemkart India IPO Details: Company Profile
Let’s take a look at the important information related to the Chemkart India IPO.
Particulars | Details |
Established | 2020 |
Registered Office | Mumbai, Maharashtra |
Promoter | Ankit Shailesh Mehta |
Products | Amino Acids, Health Supplement, Herbal Extract, Nucleotide, Protein, Sports Nutrition, Vitamin and many more |
Warehousing Facility | Spreads across 28,259.16 Sq Ft. |
Competitors | No Competitors in India |
Exploring the Chemkart India IPO Details
Check everything about the company before you go for the Chemkart India IPO subscription.
Take a look at the official IPO calendar to get a better Chemkart India IPO review.
Event Description | Date |
Start of public issue | 07 Jul 2025 |
Last date to submit IPO applications | 09 Jul 2025 |
Deadline for UPI authorisation (payment confirmation) | 09 Jul 2025 (5 PM) |
Basis of allotment finalised | 10 Jul 2025 |
Refunds begin for unallotted applicants | 11 Jul 2025 |
Equity shares credited to demat accounts | 11 Jul 2025 |
Expected listing on the stock exchange | 12 Jul 2025 |
Expiry of the UPI mandate validity period | 24 Jul 2025 |
50% lock-in ends for anchor investors | 09 Aug 2025 |
Full lock-in period ends for anchor investors | 08 Oct 2025 |
Chemkart India IPO lot size
Discover Chemkart IPO lot size here.
Particulars | Number of Equity Shares | Aggregate Value |
Fresh Issue | 26,00,000 | ₹64.48 crores |
Offer for Sale | 6,29,200 | ₹15.60 crores |
Overall Issue | 32,29,200 | ₹80.18 crores |
Understand the allocation strategy of Chemkart India.
Use of Proceeds | Amount (₹ lakhs) |
Investment in a wholly-owned subsidiary (Easy Raw Materials Private Limited) for setting up a manufacturing unit | 3,468.33 |
Payment or partial settlement of existing borrowings taken by the company | 2,000.00 |
Allocation for general business purposes | Not Disclosed |
Other takeaways from the Chemkart India IPO Price
Let’s walk through the important Chemkart India IPO share price details.
Particulars | Description |
Face value of each share | ₹10 |
Price Range | ₹236 - ₹248 |
Listed At | BSE SME |
Categorisation of different investors
The bid limits for retail investors, HNIs, and QIBs have been clearly outlined here.
Particulars | Market Maker | QIBs | Non-Institutional Investors | Retail Individual Investors |
Number of Equity Shares | 1,66,200 | Not more than 15,21,000 shares | Not less than 4,63,200 shares | Not less than 10,78,800 shares |
Minimum Bid Size | Not Disclosed | In multiples as per investment norms | Above ₹2,00,000 | More than two lots |
Maximum Bid Size | Not Disclosed | Up to full offer size (excluding anchor) | As per legal limits and offer size | Subject to legal cap and lot multiples |
Open your Demat account today to apply for the Chemkart India IPO and start your investment journey without missing out!
Chemkart India IPO details: Key Financials
The numbers below reveal if margins and revenue are moving in the right direction.
Particulars | 2025 (₹ lakhs) | 2024 (₹ lakhs) | 2023 (₹ lakhs) |
Equity Share Capital | 949.90 | 135.70 | 135.70 |
Net Worth | 5,328.57 | 2,901.47 | 1,449.65 |
Total Income | 20,545.63 | 13,282.77 | 13,168.62 |
Restated Profit/(Loss) After Tax | 2,425.75 | 1,451.82 | 766.02 |
Earnings Per Share (Basic & Diluted) | 25.54 | 15.28 | 8.06 |
Net Asset Value Per Equity Share | 56.10 | 30.55 | 15.26 |
Total Borrowings | 1,702.82 | 1,254.75 | 1,133.22 |
Metrics of Chemkart India IPO
Key Financial Performance | March 31, 2025 | March 31, 2024 | March 31, 2023 |
EBITDA Margin | 16.12% | 15.84% | 8.41% |
Net Profit Ratio | 0.12 | 0.11 | 0.06 |
Return on Equity | 0.59 | 0.67 | 0.72 |
Return on Capital Employed | 0.49 | 0.51 | 0.43 |
Debt-Equity Ratio | 0.32 | 0.43 | 0.78 |
Net Fixed Asset Turnover Ratio | 23.40 | 24.81 | 23.68 |
Current Ratio | 2.36 | 1.99 | 1.41 |
Strengths and risks
Here’s a balanced review that brings out the full picture of the Chemkart India IPO for better decision-making.
Strengths
Located close to Mumbai port, so goods move quickly from the ship to storage.
Quick to spot trends, which helps launch new products faster than others.
Good ties with B2B clients bring repeat orders and steady relationships.
Covers many health product types, so it attracts a wide range of customers.
Risks
Negative cash flow in recent times might limit business growth.
Too much dependence on a few suppliers, and there are no binding deals in place.
Losing rented office space might affect daily work and bring extra costs.
Not much background in the health supplement field may affect quality checks or future plans.
IPO Closing Soon: Is Chemkart India IPO Worth the Rush?
At this point, the Chemkart India IPO GMP hasn’t been active. But be sure to check the Chemkart India share price and important deadlines so you don’t miss any steps before allotment.
Get started with your Chemkart India IPO allotment process today.